NEWS ARCHIVE
2021-08-24 00:19:17 | Overcoming obstacles to promote repair in multiple sclerosis
Scientists at Akassoglou Lab identifying toxic elements that inhibit repair of damaged myelin and producing studies to find new treatments. To view full article click here.
2021-07-09 19:46:48 | Zhaoqi Yan – BrightFocus Alzheimer’s Disease Research Program Award Recipient
Since 1985, the Alzheimer's Disease Research (ADR) program has awarded nearly $140 million to support promising research in fields ranging from molecular biology to genetics to epidemiology. ADR is currently supporting 133 outstanding biomedical researcher projects.
2021-06-24 16:20:55 | AARP’s $60 Million Investment in Dementia Research Continues to Pay Off
A small team of scientists at the Akassoglou Lab is working on what could be a big breakthrough in treating dementia and other brain diseases. To read full article , click here.
2021-06-24 00:00:00 | AARP’s $60 Million Investment in Dementia Research Continues to Pay Off Learn more
2021-05-13 16:17:07 | Therini Raises $17M to Bring Antibody to Myelin-damaging Protein Into Trials
Therini Bio announced raising $17 million in a financing round to speed the development of an antibody that might treat people with inflammatory conditions, such as multiple sclerosis (MS), associated with damage to blood vessels. To read full article, click here.
2021-05-13 00:00:00 | Therini Raises $17M to Bring Antibody to Myelin-damaging Protein Into Trials Learn more
2021-04-01 00:00:00 | ERT Greek Public Broadcast – Katerina Akassoglou Learn more
2021-03-26 18:46:28 | Leading the Way to Better Treatments for People with Epilepsy
Gladstone researchers harness unique tools and perspectives to pave the way to more and better treatment options for epilepsy. To read full article, click here.
2021-03-24 00:00:00 | Top US Cities for Women in STEM Learn more
2021-03-01 23:22:32 | Our image was selected for the cover of The American Journal of Pathology March 2021 Issue
Network of Co-Expressed Proteins in Cerebrospinal Fluid from Patients with CNS Lymphoma . The American Journal of Pathology, Volume 191, Issue 3, P417-588.
2021-02-18 22:10:17 | New Link between Lymphoma Growth and Blood-Brain Barrier Discovered
Abnormal leaks in the blood-brain barrier have previously been linked to the severity of CNS lymphoma. However, the molecular details remain unclear. Now, the Akassoglou Lab has shown in mice that CNS B-cell lymphoma cells cluster at sites where there is a leak in the blood-brain barrier. They also found that a blood protein called fibrinogen, which normally participates in blood clotting, promotes this clustering. To read full article, click here.
Gladstone scientist Jae Kyu Ryu, PhD, (right) and his colleagues discover new links between lymphoma growth and leaks in the blood-brain barrier.
2021-01-28 19:11:57 | New Research Center to Tackle Brain Diseases
Katerina Akassoglou will lead the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which brings together a unique combination of expertise to enable novel therapies for Alzheimer Alzheimer’s disease and multiple sclerosis. To read full article, click here.
2021-01-28 19:09:21 | The Simon Family Trust Donates $2.5 Million to Biomedical Science
A generous philanthropic gift from the Simon Family Trust is supporting the creation of the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which will be led by Katerina Akassoglou, PhD, senior investigator at Gladstone Institutes. The $2.5-million donation will help scientists study neurological diseases by combining basic and clinical research in vascular biology, immunology, and neuroscience. To read full article, click here.
Photo: Simon Family
2021-01-28 00:00:00 | New Research Center to Tackle Brain Diseases Learn more
2021-01-28 00:00:00 | The Simon Family Trust Donates $2.5 Million to Biomedical Science Learn more
2021-01-14 22:17:24 | Our Article was Selected for the Cover Image of Nature Neuroscience January 2021 Issue
2021-01-11 19:05:31 | New seizure-preventing role identified for brain immune cells
Akassoglou Lab Researchers discovered in mice studies that the brain's microglia, cells that constantly monitor surrounding neurons, keep spontaneous seizures in check by tempering neuronal hyperactivity. To read full article, click here.
(AP Photo/David Duprey)
2020-12-14 19:21:53 | An Unexpected Role for the Brain’s Immune Cells
In the new study, Akassoglou and her team show that microglia (yellow) extend their branches to touch nearby neurons (blue and green), preventing these neurons from becoming overly active and causing seizures. Video by Keun-Young Kim, Gladstone Institutes. To read full article, click here.
2020-10-14 03:10:23 | Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases
Andrew Mendiola, PhD named 2020 Berkelhammer Scholar
2020-08-27 03:01:42 | Unlocking the Drivers of Neuroinflammation in Neurodegenerative Disease
To read full article, click here.
Scientists at Akassoglou Lab identifying toxic elements that inhibit repair of damaged myelin and producing studies to find new treatments. To view full article click here.2021-07-09 19:46:48 | Zhaoqi Yan – BrightFocus Alzheimer’s Disease Research Program Award Recipient
Since 1985, the Alzheimer's Disease Research (ADR) program has awarded nearly $140 million to support promising research in fields ranging from molecular biology to genetics to epidemiology. ADR is currently supporting 133 outstanding biomedical researcher projects.2021-06-24 16:20:55 | AARP’s $60 Million Investment in Dementia Research Continues to Pay Off
A small team of scientists at the Akassoglou Lab is working on what could be a big breakthrough in treating dementia and other brain diseases. To read full article , click here. 2021-06-24 00:00:00 | AARP’s $60 Million Investment in Dementia Research Continues to Pay Off Learn more
2021-05-13 16:17:07 | Therini Raises $17M to Bring Antibody to Myelin-damaging Protein Into Trials
Therini Bio announced raising $17 million in a financing round to speed the development of an antibody that might treat people with inflammatory conditions, such as multiple sclerosis (MS), associated with damage to blood vessels. To read full article, click here.2021-05-13 00:00:00 | Therini Raises $17M to Bring Antibody to Myelin-damaging Protein Into Trials Learn more
2021-04-01 00:00:00 | ERT Greek Public Broadcast – Katerina Akassoglou Learn more
2021-03-26 18:46:28 | Leading the Way to Better Treatments for People with Epilepsy
Gladstone researchers harness unique tools and perspectives to pave the way to more and better treatment options for epilepsy. To read full article, click here. 2021-03-24 00:00:00 | Top US Cities for Women in STEM Learn more
2021-03-01 23:22:32 | Our image was selected for the cover of The American Journal of Pathology March 2021 Issue
Network of Co-Expressed Proteins in Cerebrospinal Fluid from Patients with CNS Lymphoma . The American Journal of Pathology, Volume 191, Issue 3, P417-588.2021-02-18 22:10:17 | New Link between Lymphoma Growth and Blood-Brain Barrier Discovered
Abnormal leaks in the blood-brain barrier have previously been linked to the severity of CNS lymphoma. However, the molecular details remain unclear. Now, the Akassoglou Lab has shown in mice that CNS B-cell lymphoma cells cluster at sites where there is a leak in the blood-brain barrier. They also found that a blood protein called fibrinogen, which normally participates in blood clotting, promotes this clustering. To read full article, click here.
Gladstone scientist Jae Kyu Ryu, PhD, (right) and his colleagues discover new links between lymphoma growth and leaks in the blood-brain barrier.2021-01-28 19:11:57 | New Research Center to Tackle Brain Diseases
Katerina Akassoglou will lead the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which brings together a unique combination of expertise to enable novel therapies for Alzheimer Alzheimer’s disease and multiple sclerosis. To read full article, click here.
2021-01-28 19:09:21 | The Simon Family Trust Donates $2.5 Million to Biomedical Science
A generous philanthropic gift from the Simon Family Trust is supporting the creation of the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which will be led by Katerina Akassoglou, PhD, senior investigator at Gladstone Institutes. The $2.5-million donation will help scientists study neurological diseases by combining basic and clinical research in vascular biology, immunology, and neuroscience. To read full article, click here.
Photo: Simon Family2021-01-28 00:00:00 | New Research Center to Tackle Brain Diseases Learn more
2021-01-28 00:00:00 | The Simon Family Trust Donates $2.5 Million to Biomedical Science Learn more
2021-01-14 22:17:24 | Our Article was Selected for the Cover Image of Nature Neuroscience January 2021 Issue
2021-01-11 19:05:31 | New seizure-preventing role identified for brain immune cells
Akassoglou Lab Researchers discovered in mice studies that the brain's microglia, cells that constantly monitor surrounding neurons, keep spontaneous seizures in check by tempering neuronal hyperactivity. To read full article, click here.
(AP Photo/David Duprey)2020-12-14 19:21:53 | An Unexpected Role for the Brain’s Immune Cells
In the new study, Akassoglou and her team show that microglia (yellow) extend their branches to touch nearby neurons (blue and green), preventing these neurons from becoming overly active and causing seizures. Video by Keun-Young Kim, Gladstone Institutes. To read full article, click here.2020-10-14 03:10:23 | Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases
Andrew Mendiola, PhD named 2020 Berkelhammer Scholar2020-08-27 03:01:42 | Unlocking the Drivers of Neuroinflammation in Neurodegenerative Disease
To read full article, click here.
Illustration of amyloid plaques on a nerverticale cell.
